retinopathy semaglutide Semaglutide-eye-catching results Semaglutide not associated with risk

Method: Retrospectively data was collected since January 2023 from electronically maintained database of patient of a prospective study

Kurnool S, McCowen KC, Bernstein NA, et al

Expected results : 50-70% pain reduction, improved function, better stairs/squatting

While estrogen and cortisol are not standard lab tests for patients taking GLP-1 medications (unless the patient has pre-existing conditions like PCOS or an adrenal disorder or is exhibiting specific symptoms), there is a growing body of research that indicates the drugs can affect and interact with these hormones, especially in certain patient populations, like women navigating menopause